Liposomal Vitamin C 1000 mg Natural Orange Flavor

Liposomal Vitamin C 1000 mg Natural Orange Flavor

California Gold Nutrition4.5 (4,653 ratings)
Format:Liquid
Goals
$36.00 $0.00 per serving

Product analysis

55 out of 100

Liposomal Vitamin C 1000 mg Natural Orange Flavor supplies vitamin C for normal nutritional needs, with modest evidence for shorter colds when used regularly. Its cost comparison suggests weak value, and the delivery wording does not establish added benefit.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality37

Vitamin C is identified as sodium ascorbate, but its relative form quality remains uncertain. The delivery description does not establish superior effects, and other components are less clearly described.

Ingredient Transparency78

Ingredient amounts are stated, making the serving quantities clear. Unspecified forms limit comparison with more clearly described preparations.

Value For Money22

The vitamin C comparison suggests weak value for the amount delivered. An older sodium comparison also suggests weak value, while other components lack reliable comparisons.

Customer Satisfaction84

Customer feedback is favorable across a substantial number of ratings. The broad feedback base supports confidence in satisfaction without establishing health benefits.

Product Focus75

Vitamin C provides a clear nutritional focus, with modest support for shorter colds during regular use. Broader skin, eye and inflammation benefits are more uncertain and do not follow from a larger serving alone.

Format
Liquid
Customer rating
4.5 · 4,653 ratings
Report analysis

Goals

Immunity
Impact
Highest effect
B Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
Vitamin C · 1000 mg

Vitamin C has modest findings for shorter colds with regular use. That does not establish prevention of infection or treatment after a cold has begun. The 1000 mg serving reaches the saved full amount comparison, without proving an optimal dose or extra benefit from larger amounts. Sodium ascorbate receives no assumed superiority over other verified vitamin C forms.

How this product is rated for Immunity

Ingredient fit80

Vitamin C is counted with full amount coverage; other actives reduce the formula's focus.
Goal fit
Other actives and links to other goals reduce focus on vitamin C's immune contribution.
Dose adequacy
The serving reaches full amount coverage without establishing an optimal dose or verified daily use.

Pathways60

Vitamin C supplies the innate immune-cell category's contribution.
Depth
Innate immune-cell activity reaches full coverage.
Breadth
Only innate immune-cell activity meets the coverage threshold.

Evidence100

Vitamin C supplies the evidence finding, limited to modest regular-use cold-duration support.
Evidence strength
C leads the evidence contribution without establishing infection prevention or treatment after symptoms begin.
Studied preparation
The vitamin C declaration receives full preparation recognition without a buffered-form advantage.

Formulation logic100

Vitamin C satisfies partner requirements and no configured conflict was found.
Partner coverage
Vitamin C lacks no required partner.
Conflicts
No configured ingredient conflict was matched.
Effective doses
Vitamin C passes the minimum amount threshold.
Study evidence
Vitamin C Supportive 53 studies
Everyday Health
Impact
High effect
B Ingredient FitD+ PathwaysB- EvidenceA+ Formulation Logic
Vitamin C · 1000 mg

Vitamin C offers a nutritional contribution when dietary intake is low. The saved findings strongly recognize its amount, but large servings do not establish extra general-health benefit above adequate intake. The supplied context does not support prevention of infection, cancer or cardiovascular disease from this contribution.

How this product is rated for Everyday Health

Ingredient fit80

Vitamin C receives strong amount recognition.
Goal fit
Ingredients outside the reviewed scope and links to other goals reduce the formula’s focus.
Dose adequacy
The evaluated amounts receive full recognition; this does not establish additional benefit beyond adequate intake.

Pathways54

Vitamin C supplies the antioxidant-and-immune-defence finding.
Depth
Vitamin C supplies the antioxidant-and-immune-defence finding.
Breadth
Coverage is concentrated in one functional area.

Evidence74

Vitamin C evidence supports conditional nutrient availability rather than broad disease prevention.
Evidence strength
Vitamin C evidence supports conditional nutrient availability rather than broad disease prevention.
Studied preparation
The evaluated nutrient declarations are recognized without a bonus for chemical form or delivery method.

Formulation logic100

The recognized ingredients have their required partners or work independently, with no matched formulation conflict.
Partner coverage
Recognized ingredients have any required partner or work independently; this does not establish added combination benefit.
Conflicts
No matched formulation conflict appears in the supplied findings.
Effective doses
All included ingredients meet the saved amount threshold; it is not a guarantee of clinical benefit or safety.
Study evidence
Vitamin C Supportive 56 studies
Skin Health
Impact
High effect
B Ingredient FitF PathwaysA+ EvidenceA+ Formulation Logic
Vitamin C · 1000 mg

Vitamin C is needed to build collagen and maintain normal wound healing. Correcting low intake can restore these functions, but extra vitamin C has no established skin benefit when intake is adequate. The supplied evidence does not show added cosmetic or UV-protection benefits from the large serving amount or the named delivery form.

How this product is rated for Skin Health

Ingredient fit80

Relevant ingredients share this formula with actives aimed at other purposes. The relevant amount reaches the recorded exposure comparison; this does not establish added skin benefit.
Goal fit
Relevant ingredients share this formula with actives aimed at other purposes.
Dose adequacy
The relevant amount reaches the recorded exposure comparison; this does not establish added skin benefit.

Pathways0

No direct contribution to the four tracked skin mechanisms was recorded, despite vitamin C’s normal nutritional role.
Depth
No direct contribution to the four tracked skin mechanisms was recorded, despite vitamin C’s normal nutritional role.
Breadth
No tracked skin mechanism reaches the recorded coverage threshold.

Evidence100

Vitamin C’s role in collagen and deficiency-related healing is established; extra cosmetic benefit in adequately nourished adults is not.
Evidence strength
Vitamin C’s role in collagen and deficiency-related healing is established; extra cosmetic benefit in adequately nourished adults is not.
Studied preparation
The recorded preparation comparison is satisfied, but preparation-specific study findings do not automatically transfer to every ingredient or finished product.

Formulation logic100

No required partner was missing and no defined conflict was identified. The relevant amounts meet the recorded minimum comparison; this is not proof of a clinically effective skin dose.
Partner coverage
No required partner was missing in the recorded findings; this does not establish an added combination benefit.
Conflicts
No defined ingredient conflict was identified in the supplied findings.
Effective doses
The relevant amounts meet the recorded minimum comparison; this is not proof of a clinically effective skin dose.
Study evidence
Vitamin C Supportive 53 studies
Impact
High effect
B Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Vitamin C · 1000 mg

Vitamin C supports antioxidant defenses. Its relevant inflammation finding came from people with elevated baseline CRP, while the overall trial was null, so a general anti-inflammatory benefit is uncertain. Sodium ascorbate has no established anti-inflammatory advantage over other vitamin C forms.

How this product is rated for Inflammation

Ingredient fit80

The formula includes ingredients for other purposes, which reduces its focus on inflammation-related support. The counted amount reaches the saved exposure comparison; this does not establish a proven effective daily regimen.
Goal fit
The formula includes ingredients for other purposes, which reduces its focus on inflammation-related support.
Dose adequacy
The counted amount reaches the saved exposure comparison; this does not establish a proven effective daily regimen.

Pathways55

The strongest recorded connection is oxidative and mitochondrial stress, with substantial coverage in the saved comparison. Coverage remains concentrated in one route.
Depth
The strongest recorded connection is oxidative and mitochondrial stress, with substantial coverage in the saved comparison.
Breadth
One pathway reaches the saved coverage threshold; the formula does not provide broad coverage across the inflammation-related routes.

Evidence87

Vitamin C supplies the recorded human-evidence contribution. The relevant signal was limited to elevated baseline CRP.
Evidence strength
Vitamin C supplies the recorded human-evidence contribution.
Studied preparation
The counted preparations match those recognized in the saved comparison; this does not establish equivalent clinical results.

Formulation logic100

Partner requirements are met and no configured conflict was recorded. The counted ingredients reach the saved amount threshold.
Partner coverage
The counted ingredients can stand alone or have the partners required by the saved comparison; no added benefit from combining them is established.
Conflicts
No configured ingredient conflict was recorded; this finding is limited to the interactions checked.
Effective doses
The counted ingredients meet the saved minimum amount threshold; that threshold is not a proven effective dose.
Study evidence
Vitamin C Supportive 50 studies
Impact
High effect
B Ingredient FitD PathwaysC+ EvidenceA+ Formulation Logic
Vitamin C · 1000 mg

Vitamin C has an antioxidant role relevant to eye tissues. Its supplied vision evidence comes from a defined multi-ingredient regimen in selected people with macular degeneration, which does not establish vitamin C-alone improvement in routine visual performance. The declared serving meets the saved amount comparison, but neither its amount nor form establishes the same clinical benefit.

How this product is rated for Eye Health

Ingredient fit80

Vitamin C supplies the main eye-related connection.
Goal fit
Vitamin C supplies the main eye-related connection.
Dose adequacy
Vitamin C meets the saved amount comparison; this does not establish a standalone dose that improves vision.

Pathways47

The saved findings concentrate on retinal and lens antioxidant defence.
Depth
The saved findings concentrate on retinal and lens antioxidant defence.
Breadth
One route reaches substantial coverage; broader coverage of other vision-related routes is limited.

Evidence68

Vitamin C's supplied evidence concerns a defined combination in selected macular-degeneration populations.
Evidence strength
Vitamin C's supplied evidence concerns a defined combination in selected macular-degeneration populations.
Studied preparation
The declared vitamin C form is recognized, without establishing a form-specific visual advantage.

Formulation logic100

The included ingredients need no missing partner, and no configured ingredient conflict was found.
Partner coverage
The included ingredients work independently or have their required partner.
Conflicts
No configured ingredient conflict was found.
Effective doses
All included ingredients meet the saved minimum amount comparison; this threshold does not establish clinical effectiveness.
Study evidence
Vitamin C Disputed 24 studies

Ingredients

IngredientAmount per servingScore
Calories
5 Calorie(s)
Total Fat
0.5 Gram(s)
Vitamin C (Sodium Ascorbate)
1000 mg 72
Sodium (Sodium Ascorbate)
120 mg 49
Phosphatidylcholine
500 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
A+ Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyF Value
D Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyF Value
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies.
    Aune D; Keum N; Giovannucci E; Fadnes LT; Boffetta P; Greenwood DC; Tonstad S; Vatten LJ; Riboli E; Norat T · The American journal of clinical nutrition · 2019
    Meta-analysis69 studies pooledEveryday Health forVitamin C
  2. Scientific Opinion on the substantiation of a health claim related to vitamin C and increasing non haem iron absorption pursuant to Article 14 of Regulation (EC) No 1924/2006.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) · EFSA journal. European Food Safety Authority · 2026
    Guideline / consensusEveryday Health forVitamin C
  3. Vitamin C Depletion and All-Cause Mortality in Renal Transplant Recipients.
    Sotomayor CG; Eisenga MF; Gomes Neto AW; Ozyilmaz A; Gans ROB; Jong WHA; Zelle DM; Berger SP; Gaillard CAJM; Navis GJ; Bakker SJ · Nutrients · 2018
    Cohort study598 participantsEveryday Health forVitamin C
  4. Associations of Serum Biomarkers of Fruit and Vegetable Intake With the Risk of Cause-Specific Mortality and All-Cause Mortality: A National Prospective Cohort Study.
    Pu L; Zhang R; Wang X; Zhao T; Sun H; Han L · Frontiers in nutrition · 2022
    Cohort study12,530 participantsEveryday Health forVitamin C
  5. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition.
    Khaw KT; Bingham S; Welch A; Luben R; Wareham N; Oakes S; Day N · Lancet (London, England) · 2001
    Cohort study19,496 participantsEveryday Health forVitamin C
  6. Role of Oral Vitamin 'C' on Astigmatic Errors in Phacoemulsification.
    Mohan S; Sah K; Khattri M; Ahmad L; Sachan SK · Current eye research · 2021
    Randomized trial400 participantsEye Health forVitamin C
  7. Ascorbic acid metabolites are involved in intraocular pressure control in the general population.
    Hysi PG; Khawaja AP; Menni C; Tamraz B; Wareham N; Khaw KT; Foster PJ; Benet LZ; Spector TD; Hammond CJ · Redox biology · 2019
    Observational studyEye Health forVitamin C
  8. Nutritional modulation of cataract.
    Weikel KA; Garber C; Baburins A; Taylor A · Nutrition reviews · 2014
    Narrative reviewEye Health forVitamin C
  9. Dietary n-3 Fatty Acid, α-Tocopherol, Zinc, vitamin D, vitamin C, and β-carotene are Associated with Age-Related Macular Degeneration in Japan.
    Aoki A; Inoue M; Nguyen E; Obata R; Kadonosono K; Shinkai S; Hashimoto H; Sasaki S; Yanagi Y · Scientific reports · 2017
    Case-control study530 participantsEye Health forVitamin C
  10. Adherence to a Mediterranean diet, lifestyle and age-related macular degeneration: the Coimbra Eye Study - report 3.
    Raimundo M; Mira F; Cachulo MDL; Barreto P; Ribeiro L; Farinha C; Laíns I; Nunes S; Alves D; Figueira J; Merle BM; Delcourt C; Santos L; Silva R · Acta ophthalmologica · 2019
    Case-control study883 participantsEye Health forVitamin C
  11. Vitamin C and contribution to the normal function of the immune system: evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) · EFSA journal. European Food Safety Authority · 2026
    Guideline / consensusImmunity forVitamin C
  12. Therapeutic effects of high-dose vitamin C supplementation in patients with COVID-19: a meta-analysis.
    Sun L; Zhao JH; Fan WY; Feng B; Liu WW; Chen RQ; Ban C; Dang AG; Wang M; Luo KT; Zhou GY; Yu FF; Ba Y · Nutrition reviews · 2024
    Meta-analysis2,334 participants14 studies pooledImmunity forVitamin C
  13. Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis.
    Abioye AI; Bromage S; Fawzi W · BMJ global health · 2021
    Meta-analysisImmunity forVitamin C
  14. New evidence for antioxidant properties of vitamin C.
    Vojdani A; Bazargan M; Vojdani E; Wright J · Cancer detection and prevention · 2001
    Randomized trial20 participantsImmunity forVitamin C
  15. Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults.
    Calder PC; Kreider RB; McKay DL · Nutrients · 2025
    Systematic review13 studies pooledImmunity forVitamin C
  16. Efficacy of Vitamin C as Glucocorticoid Substitute for Reducing Pain and Inflammation After Total Hip Arthroplasty: A Randomized Controlled Trial.
    Jiang W; Xu H; Jiang X; Zhan Y; Ju Y; Xie J; Huang Z; Huang Q; Pei F · The Journal of bone and joint surgery. American volume · 2025
    Randomized trial107 participantsInflammation forVitamin C
  17. The Impact of Vitamin C on Analgesic, Anti-inflammatory, and Hemostatic Outcomes After Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Moftakhari Hajimirzaei S; Bagherzadeh Cham M; Dolikhani M; Tabatabaee SM; Ebrahimpour A · The archives of bone and joint surgery · 2026
    Meta-analysis1,162 participants10 studies pooledInflammation forVitamin C
  18. The impact of vitamin C supplementation on the perioperative outcomes after total hip and knee arthroplasty: a systematic review and meta-analysis.
    Liu X; Guo J; Li Y; Yang Y; Liu M; Gao Q; Yang Y; Wu X; Yue C · BMC musculoskeletal disorders · 2026
    Meta-analysis852 participants8 studies pooledInflammation forVitamin C
  19. Therapeutic Impact of Ascorbic Acid on Oral and Periodontal Tissues: A Systematic Literature Review.
    Ruzijevaite G; Acaite E; Jagelaviciene E · Medicina (Kaunas, Lithuania) · 2025
    Systematic review811 participants17 studies pooledInflammation forVitamin C
  20. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation.
    Korantzopoulos P; Kolettis TM; Kountouris E; Dimitroula V; Karanikis P; Pappa E; Siogas K; Goudevenos JA · International journal of cardiology · 2005
    Randomized trial44 participantsInflammation forVitamin C